ES545189A0 - Un metodo para preparar peptidos farmaceuticamente activos - Google Patents

Un metodo para preparar peptidos farmaceuticamente activos

Info

Publication number: ES545189A0
Authority: ES; Spain
Prior art keywords: sup; hydrogen; pharmaceutically active; carbamyl; active peptides
Prior art date: 1983-05-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

ES545189A

Other languages

English (en)

Other versions

ES8604991A1 (es

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Wellcome Foundation Ltd

Original Assignee

Wellcome Foundation Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-05-26

Filing date

1985-07-15

Publication date

1986-03-01

1985-07-15 Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd

1986-03-01 Publication of ES8604991A1 publication Critical patent/ES8604991A1/es

1986-03-01 Publication of ES545189A0 publication Critical patent/ES545189A0/es

Status Expired legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/70—Enkephalins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Neurosurgery (AREA)
Cardiology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Toxicology (AREA)
Addiction (AREA)
Psychiatry (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

ES545189A 1983-05-26 1985-07-15 Un metodo para preparar peptidos farmaceuticamente activos Expired ES8604991A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB838314646A GB8314646D0 (en)	1983-05-26	1983-05-26	Pharmaceutical amides

Publications (2)

Publication Number	Publication Date
ES8604991A1 ES8604991A1 (es)	1986-03-01
ES545189A0 true ES545189A0 (es)	1986-03-01

Family

ID=10543432

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
ES532813A Expired ES8606395A1 (es)	1983-05-26	1984-05-25	Un metodo de preparar peptidos farmaceuticamente activos
ES545189A Expired ES8604991A1 (es)	1983-05-26	1985-07-15	Un metodo para preparar peptidos farmaceuticamente activos

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
ES532813A Expired ES8606395A1 (es)	1983-05-26	1984-05-25	Un metodo de preparar peptidos farmaceuticamente activos

Country Status (17)

Country	Link
US (1)	US4540682A (es)
EP (1)	EP0127154B1 (es)
JP (1)	JPS59231053A (es)
KR (1)	KR850000467A (es)
AT (1)	ATE57188T1 (es)
AU (1)	AU575324B2 (es)
CA (1)	CA1251898A (es)
DE (1)	DE3483338D1 (es)
DK (1)	DK258884A (es)
ES (2)	ES8606395A1 (es)
FI (1)	FI82254C (es)
GB (1)	GB8314646D0 (es)
GR (1)	GR81890B (es)
HU (1)	HU193569B (es)
IL (1)	IL71932A (es)
NZ (1)	NZ208283A (es)
ZA (1)	ZA844004B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8622090D0 (en) *	1986-09-12	1986-10-22	Wellcome Found	Pharmacologically active compounds
US5663146A (en) *	1991-08-22	1997-09-02	Administrators Of The Tulane Educational Fund	Polypeptide analogues having growth hormone releasing activity
US6258550B1 (en)	1993-04-23	2001-07-10	Virginia Commonwealth University	Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5965698A (en) *	1993-04-23	1999-10-12	Virginia Commonwealth University	Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US5928896A (en) *	1993-04-23	1999-07-27	Virginia Commonwealth University	Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
AU6770794A (en) *	1993-04-23	1994-11-21	Herbert J. Evans	Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5952465A (en) *	1993-04-23	1999-09-14	Virginia Commonwealth University	Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US6084066A (en) *	1993-10-29	2000-07-04	Virginia Commonwealth University	Polypetides that include conformation-constraining groups which flank a protein-protein interaction site
US5962477A (en) *	1994-04-12	1999-10-05	Adolor Corporation	Screening methods for cytokine inhibitors
US6190691B1 (en)	1994-04-12	2001-02-20	Adolor Corporation	Methods for treating inflammatory conditions
US6573282B1 (en)	1995-09-12	2003-06-03	Adolor Corporation	Peripherally active anti-hyperalgesic opiates
US5849761A (en)	1995-09-12	1998-12-15	Regents Of The University Of California	Peripherally active anti-hyperalgesic opiates
US6312893B1 (en)	1996-01-23	2001-11-06	Qiagen Genomics, Inc.	Methods and compositions for determining the sequence of nucleic acid molecules
US6613508B1 (en)	1996-01-23	2003-09-02	Qiagen Genomics, Inc.	Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques
US6027890A (en) *	1996-01-23	2000-02-22	Rapigene, Inc.	Methods and compositions for enhancing sensitivity in the analysis of biological-based assays
US6372717B1 (en) *	1996-08-23	2002-04-16	Sederma S.A.	Synthetic peptides and their use in cosmetic or dermopharmaceutical compositions
AU2007285045A1 (en) *	2006-08-17	2008-02-21	Eribis Pharmaceuticals Ab	Cardioprotective compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4178371A (en) *	1977-12-15	1979-12-11	Reckitt & Colman Products Limited	Tetrapeptide derivatives
US4288432A (en) *	1979-06-12	1981-09-08	Richter Gedeon Vegyeszeti Gyar Rt.	Novel enkephalin analogs and process for the preparation thereof
US4265808A (en) *	1979-12-17	1981-05-05	Eli Lilly And Company	Pharmacologically active peptides
US4322339A (en) *	1980-10-20	1982-03-30	Eli Lilly And Company	Pharmacologically active peptides

1983
- 1983-05-26 GB GB838314646A patent/GB8314646D0/en active Pending
1984
- 1984-05-23 US US06/613,868 patent/US4540682A/en not_active Expired - Lifetime
- 1984-05-25 AU AU28701/84A patent/AU575324B2/en not_active Ceased
- 1984-05-25 JP JP59106325A patent/JPS59231053A/ja active Pending
- 1984-05-25 EP EP84105981A patent/EP0127154B1/en not_active Expired - Lifetime
- 1984-05-25 GR GR74826A patent/GR81890B/el unknown
- 1984-05-25 NZ NZ208283A patent/NZ208283A/xx unknown
- 1984-05-25 DE DE8484105981T patent/DE3483338D1/de not_active Expired - Fee Related
- 1984-05-25 ZA ZA844004A patent/ZA844004B/xx unknown
- 1984-05-25 CA CA000455145A patent/CA1251898A/en not_active Expired
- 1984-05-25 IL IL71932A patent/IL71932A/xx unknown
- 1984-05-25 AT AT84105981T patent/ATE57188T1/de not_active IP Right Cessation
- 1984-05-25 HU HU842048A patent/HU193569B/hu not_active IP Right Cessation
- 1984-05-25 FI FI842104A patent/FI82254C/fi not_active IP Right Cessation
- 1984-05-25 ES ES532813A patent/ES8606395A1/es not_active Expired
- 1984-05-25 KR KR1019840002863A patent/KR850000467A/ko not_active Ceased
- 1984-05-25 DK DK258884A patent/DK258884A/da not_active Application Discontinuation
1985
- 1985-07-15 ES ES545189A patent/ES8604991A1/es not_active Expired

Also Published As

Publication number	Publication date
EP0127154A3 (en)	1987-05-06
FI82254B (fi)	1990-10-31
EP0127154A2 (en)	1984-12-05
HUT34764A (en)	1985-04-28
AU575324B2 (en)	1988-07-28
ZA844004B (en)	1986-01-29
ES8606395A1 (es)	1986-04-01
DE3483338D1 (de)	1990-11-08
EP0127154B1 (en)	1990-10-03
IL71932A0 (en)	1984-09-30
US4540682A (en)	1985-09-10
FI842104L (fi)	1984-11-27
DK258884A (da)	1984-11-27
IL71932A (en)	1987-10-20
ATE57188T1 (de)	1990-10-15
GB8314646D0 (en)	1983-06-29
GR81890B (es)	1984-12-12
KR850000467A (ko)	1985-02-27
DK258884D0 (da)	1984-05-25
ES8604991A1 (es)	1986-03-01
CA1251898A (en)	1989-03-28
JPS59231053A (ja)	1984-12-25
ES532813A0 (es)	1986-04-01
AU2870184A (en)	1984-11-29
FI842104A0 (fi)	1984-05-25
NZ208283A (en)	1988-07-28
HU193569B (en)	1987-10-28
FI82254C (fi)	1991-02-11

Publication	Publication Date	Title
ES545189A0 (es)	1986-03-01	Un metodo para preparar peptidos farmaceuticamente activos
MY115662A (en)	2003-08-30	Novel compounds with analgesic effect
ATE259232T1 (de)	2004-02-15	Verwendung von dextromethorphan oder dextrorphan zur behandlung der harninkontinenz
IL76932A (en)	1989-07-31	Synergistic pharmaceutical analgesic compositions containing dihydrocodeine and ibuprofen
EP0137543A3 (en)	1987-09-02	Pharmaceutical composition for the therapy of peripheral arteriopathies
ES2060173T3 (es)	1994-11-16	Derivados de lisolecitina para el tratamiento de enfermedades autoinmunologicas.
SE8801515D0 (sv)	1988-04-22	Farmaceutisk komposition
MY115805A (en)	2003-09-30	Substituted benzyloxycarbonylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
PT100415A (pt)	1993-06-30	Novas morfolinas de accao farmaceutica, e processo para a sua preparacao
DE3369327D1 (en)	1987-02-26	Pharmaceutical compounds, preparation, use and intermediates therefor and their preparation
ATE153500T1 (de)	1997-06-15	Verfahren zur inhibierung der fibrose
CA2090234A1 (en)	1992-03-12	Method for providing improved analgesic effect
GEP20032956B (en)	2003-04-25	Miticide Composition
ES2131331T3 (es)	1999-07-16	Uso de benzotiofenos para la preparacion de un medicamento para reducir la formacion de cicatrices en la curacion de heridas.
JO1231B1 (en)	1985-04-20	A way to treat monocytes
FR2274305A1 (fr)	1976-01-09	Medicaments a action curative sur les ulceres et leur procede de preparation